Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE: 002287)

Tibet Cheezheng Tibetan Medicine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	875.75	403.43	437.57	666.63	1,831	1,347
Short-Term Investments	-	-	224.65	107.74	-	-
Trading Asset Securities	2,163	1,963	1,539	1,184	-	32.28
Cash & Short-Term Investments	3,039	2,366	2,202	1,958	1,831	1,379
Cash Growth	8.49%	7.49%	12.42%	6.98%	32.75%	63.83%
Accounts Receivable	842.83	604.86	825.39	606.61	1,024	678.3
Other Receivables	20.65	18.34	10.03	212.89	10.83	10.32
Receivables	863.48	623.19	835.42	819.49	1,035	688.62
Inventory	164.34	156.33	127.77	118.5	94.75	61.99
Prepaid Expenses	-	1.11	6.88	1.99	2.31	1.32
Other Current Assets	49.18	47.25	20.83	38.07	9.68	4.4
Total Current Assets	4,116	3,194	3,192	2,936	2,972	2,135
Property, Plant & Equipment	1,678	1,647	1,144	821.35	579.11	545.72
Long-Term Investments	553.06	1,043	1,116	1,357	534.28	225.15
Other Intangible Assets	338.56	351.62	374.81	399.33	176.2	45.75
Long-Term Deferred Tax Assets	33.35	39.39	30.59	26.68	26.7	8.84
Long-Term Deferred Charges	4.43	4.95	3.29	5.25	0.15	0.08
Other Long-Term Assets	21.42	17.68	26.33	21.28	173.54	23.21
Total Assets	6,744	6,298	5,888	5,568	4,462	2,984
Accounts Payable	170.78	266.23	93.47	184	52.21	20.19
Accrued Expenses	280.9	352.86	330.7	297.27	254.47	233.88
Short-Term Debt	754.25	451.52	701.73	501.81	300.16	300.19
Current Portion of Long-Term Debt	70.48	9.02	54.11	103.93	6.2	-
Current Portion of Leases	4.96	6.39	6.47	5.07	-	-
Current Income Taxes Payable	18.03	55.56	25.9	9.83	11.2	9.77
Current Unearned Revenue	73.1	73.89	102.16	110.11	74.45	37.5
Other Current Liabilities	282.99	29.74	45.59	95.96	65.75	52.6
Total Current Liabilities	1,655	1,245	1,360	1,308	764.44	654.13
Long-Term Debt	1,021	1,061	929.47	836.48	901.33	-
Long-Term Leases	5.63	7	4.91	4.94	-	-
Long-Term Unearned Revenue	187.84	191.3	167.04	154.66	159.27	67.78
Long-Term Deferred Tax Liabilities	27.62	20.94	36.39	40.71	1.95	0.29
Other Long-Term Liabilities	2.6	2.6	2.6	2.6	-	-
Total Liabilities	2,900	2,528	2,501	2,347	1,827	722.2
Common Stock	530.17	530.19	530.22	530.3	530.34	530.18
Additional Paid-In Capital	454.41	477.25	476.33	480.44	474.26	457.89
Retained Earnings	2,647	2,576	2,202	2,042	1,506	1,288
Treasury Stock	-	-0.48	-8.68	-16.97	-25.28	-32.11
Comprensive Income & Other	160.66	137.25	136.4	133.14	133.33	1.23
Total Common Equity	3,793	3,720	3,336	3,169	2,619	2,246
Minority Interest	51.27	49.82	51.64	51.35	16.43	16.38
Shareholders' Equity	3,844	3,770	3,388	3,220	2,635	2,262
Total Liabilities & Equity	6,744	6,298	5,888	5,568	4,462	2,984
Total Debt	1,856	1,535	1,697	1,452	1,208	300.19
Net Cash (Debt)	1,182	831.28	504.82	506.11	622.94	1,079
Net Cash Growth	62.32%	64.67%	-0.26%	-18.75%	-42.26%	28.17%
Net Cash Per Share	2.23	1.57	0.95	0.96	1.18	2.04
Filing Date Shares Outstanding	530.17	530.19	529.64	528.63	528.03	527.84
Total Common Shares Outstanding	530.17	530.19	529.64	528.63	528.03	527.8
Working Capital	2,460	1,949	1,832	1,628	2,208	1,481
Book Value Per Share	7.15	7.02	6.30	5.99	4.96	4.25
Tangible Book Value	3,454	3,369	2,961	2,770	2,443	2,200
Tangible Book Value Per Share	6.51	6.35	5.59	5.24	4.63	4.17
Buildings	1,307	1,309	705.16	671.59	553.95	550.95
Machinery	339.49	328.81	190.32	181.58	128.32	116.66
Construction In Progress	376.26	302.75	533.08	212.04	70.57	20.72

Source: S&P Capital IQ. Standard template. Financial Sources.